Archive for the ‘Featured Topics’ Category

April 18, 2012 · by James White, MD · Education, Epilepsy News, Featured Topics, Misc Topics, Patient Information

INTRODUCTION Two new antiepileptic drugs (AEDs) have had recent FDA approval. The first medication to be discussed is clobazam (band name = Onfi). This drug is currently available. The second AED is ezogabine (brand name = Potiga). Ezogabine is not yet available in pharmacies, but should be available soon. The purpose of this article is…

April 11, 2012 · by James White, MD · Education, Featured Topics, News, Patient Information

ARTICLE HIGHLIGHTS Head trauma is one of the most commonly identified reasons that patients develop epilepsy. Most studies suggest that approximately 6% of patients with epilepsy have TBI as the cause. The more severe the head trauma, the higher the risk of developing epilepsy. For example, patients with penetrating brain injury have a 53% chance…

March 26, 2012 · by James White, MD · Education, Epilepsy News, Featured Topics, Patient Information

ARTICLE HIGHLIGHTS Stem cell therapy for epilepsy is a possible treatment option in the future. Stem cell therapy may prove useful for: Improving seizure control Improving memory issues Stem cell therapy is not yet approved for the treatment of epilepsy- the safety and effectiveness of such treatment has to be thoroughly studied and approved by…

July 13, 2011 · by James White, MD · Education, Featured Topics, Patient Information, Seizure Types, Treatment

ARTICLE HIGHLIGHTS The brand vs generic antiepileptic drug (AED) controversy remains a hot debate in the epilepsy community. Generic AEDs are often much less expensive for patients compared to brand AEDs.  However, brand AEDs may provide more reliable seizure medication levels which could potentially reduce side effects and improve seizure control. We recommend that decisions…

Newer Entries »